CNBX Pharmaceuticals Inc. (CNBX) EBITDA (2013 - 2026)
CNBX Pharmaceuticals' (CNBX) quarterly EBITDA came in at -$162763.0 in Q2 2026, down 303.08% YoY from $80147.9 in Q2 2025, and down 123.08% on a QoQ basis from -$72963.0 in Q1 2026.
CNBX Pharmaceuticals Inc. (CNBX) EBITDA (2013 - 2026) Analysis & Trends
CNBX Pharmaceuticals (CNBX) has 14 years of EBITDA data on file, last reported at -$162763.0 in Q2 2026.
- Quarterly EBITDA fell 303.08% year-over-year to -$162763.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$429459.0 (down 120.81% YoY) and the FY2025 annual result came in at -$271691.0, up 53.41% from the prior year.
- EBITDA fell to -$162763.0 in Q2 2026, from -$72963.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$36837.0 in Q4 2024 to a low of -$730261.0 in Q1 2022.
- A 5-year average of -$218308.8 and a median of -$162131.0 in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2024 — EBITDA soared 78.57% — and 2026, when it tumbled 303.08%.
- Tracing CNBX's EBITDA over 5 years: stood at -$346790.0 in 2022, then surged by 50.43% to -$171900.0 in 2023, then soared by 78.57% to -$36837.0 in 2024, then slumped by 73.74% to -$64002.0 in 2025, then tumbled by 154.31% to -$162763.0 in 2026.
- The last three EBITDA figures came in at -$162763.0 (Q2 2026), -$72963.0 (Q1 2026), and -$64002.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -162,763.00 |
| Feb 28, 2026 | -72,963.00 |
| Nov 30, 2025 | -64,002.00 |
| Aug 31, 2025 | -129,731.00 |
| May 31, 2025 | -40,380.00 |
| Feb 28, 2025 | -64,743.00 |
| Nov 30, 2024 | -36,837.00 |
| Aug 31, 2024 | -52,533.00 |
| May 31, 2024 | -152,278.00 |
| Feb 29, 2024 | -206,428.00 |
| Nov 30, 2023 | -171,900.00 |
| Aug 31, 2023 | -161,499.00 |
| May 31, 2023 | -173,082.00 |
| Feb 28, 2023 | -250,010.00 |
| Nov 30, 2022 | -346,790.00 |
| Aug 31, 2022 | -478,353.00 |
| May 31, 2022 | -635,006.00 |
| Feb 28, 2022 | -730,261.00 |
| Nov 30, 2021 | -1.11 Mn |
| Aug 31, 2021 | -596,324.00 |